US News

U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval

Published by

By Manas Mishra and Julie Steenhuysen (Reuters) -An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc and BioNTech SE COVID-19 vaccine for people age 16 and older, an important step that could help accelerate vaccine mandates in the United States. The Food and Drug Administration last week granted full approval to the vaccine that was previously available under the agency’s emergency use authorization (EUA), which had allowed the shots to be rolled out rapidly to Americans. Health officials hope the formal approval and …

Read More

Facebook Comments

Check Also

Biden Push To Turn 'Ultra MAGA' Into Disparaging Epithet Came From 6-Month Study, Was Not 'Organic'

Biden Push To Turn ‘Ultra MAGA’ Into Disparaging ...